CAE Valuation

Is CE9 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CE9 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CE9 (€21.4) is trading below our estimate of fair value (€32.43)

Significantly Below Fair Value: CE9 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CE9?

Key metric: As CE9 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CE9. This is calculated by dividing CE9's market cap by their current revenue.
What is CE9's PS Ratio?
PS Ratio2.3x
SalesCA$4.43b
Market CapCA$10.10b

Price to Sales Ratio vs Peers

How does CE9's PS Ratio compare to its peers?

The above table shows the PS ratio for CE9 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.1x
5UH Hensoldt
2x13.2%€4.2b
MTX MTU Aero Engines
2.4x8.9%€16.9b
RHM Rheinmetall
3x20.3%€26.3b
OHB OHB
0.9x16.0%€884.8m
CE9 CAE
2.3x6.3%€10.1b

Price-To-Sales vs Peers: CE9 is expensive based on its Price-To-Sales Ratio (2.3x) compared to the peer average (2.1x).


Price to Sales Ratio vs Industry

How does CE9's PS Ratio compare vs other companies in the European Aerospace & Defense Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
CE9 2.3xIndustry Avg. 1.6xNo. of Companies10PS01.22.43.64.86+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CE9 is expensive based on its Price-To-Sales Ratio (2.3x) compared to the European Aerospace & Defense industry average (1.6x).


Price to Sales Ratio vs Fair Ratio

What is CE9's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CE9 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.3x
Fair PS Ratio0.6x

Price-To-Sales vs Fair Ratio: CE9 is expensive based on its Price-To-Sales Ratio (2.3x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CE9 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€21.40
€21.41
+0.04%
13.9%€25.27€14.34n/a13
Nov ’25€16.10
€18.49
+14.8%
15.3%€22.45€12.55n/a13
Oct ’25€16.70
€18.56
+11.2%
16.9%€23.87€11.93n/a13
Sep ’25€16.00
€18.56
+16.0%
16.9%€23.87€11.93n/a13
Aug ’25€16.70
€19.26
+15.4%
15.5%€24.01€13.34n/a13
Jul ’25€17.10
€20.06
+17.3%
15.6%€24.57€13.65n/a13
Jun ’25€17.00
€20.37
+19.8%
12.8%€24.30€14.18n/a12
May ’25€17.90
€22.37
+25.0%
10.5%€27.25€17.72n/a12
Apr ’25€18.90
€22.41
+18.5%
8.6%€25.44€17.88n/a12
Mar ’25€17.20
€22.41
+30.3%
8.6%€25.44€17.88n/a12
Feb ’25€18.50
€23.97
+29.6%
9.6%€26.58€17.72n/a12
Jan ’25€19.40
€24.37
+25.6%
8.9%€26.68€17.78n/a12
Dec ’24€18.20
€23.77
+30.6%
8.7%€25.48€17.43n/a12
Nov ’24€19.70
€25.95
+31.8%
2.9%€27.50€24.75€16.1012
Oct ’24€22.00
€25.42
+15.6%
2.8%€26.50€23.78€16.7012
Sep ’24€22.20
€25.42
+14.5%
2.8%€26.50€23.78€16.0012
Aug ’24€20.60
€24.77
+20.3%
4.6%€26.08€21.97€16.7011
Jul ’24€19.90
€24.70
+24.1%
4.9%€26.26€22.11€17.1012
Jun ’24€19.10
€24.70
+29.3%
4.9%€26.26€22.11€17.0012
May ’24€20.40
€24.59
+20.6%
3.8%€25.72€22.34€17.9012
Apr ’24€20.40
€25.19
+23.5%
3.7%€26.47€22.99€18.9012
Mar ’24€21.20
€25.19
+18.8%
3.7%€26.47€22.99€17.2012
Feb ’24€20.60
€23.30
+13.1%
4.9%€24.92€20.76€18.5012
Jan ’24€18.10
€23.51
+29.9%
4.9%€25.08€20.90€19.4012
Dec ’23€20.60
€24.24
+17.7%
4.6%€25.92€21.60€18.2012
Nov ’23€19.30
€24.15
+25.1%
9.3%€27.49€19.32€19.7012

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies